'Magic bullet' found in fight against leukemia
Researchers have made a huge leap forward in finding a targeted therapy for acute myeloid leukemia.
Nov 10, 2021
0
116
Researchers have made a huge leap forward in finding a targeted therapy for acute myeloid leukemia.
Nov 10, 2021
0
116
The team of the adult nephrology-renal transplantation department of the Necker-Enfants Malades AP-HP hospital, Inserm and the University of Paris has carried out work, coordinated by Prof. Guillaume Canaud, which opens up ...
Oct 7, 2021
0
24
Renal cell carcinoma (RCC) is the most common form of kidney cancer. In 2018, there were an estimated 403,000 new cases of RCC and 175,000 deaths due to kidney cancer worldwide. Currently, the 5-year survival rate for patients ...
Jan 20, 2021
0
46
Scientists from Johns Hopkins University and Medicine have developed a possible new antibiotic for a pathogen that is notoriously resistant to medications and frequently lethal for people with cystic fibrosis and other lung ...
Dec 8, 2020
0
85
Nanoparticles continue to find wider use in medical treatments in everything from drug delivery to diagnosing disease. In nearly every case, these ultrafine particles are delivered to patients via injection or through an ...
Dec 7, 2020
0
124
Multiple sclerosis, an autoimmune disease of the central nervous system that affects millions worldwide, can cause debilitating symptoms for those who suffer from it.
Oct 13, 2020
0
123
A world first discovery of how a protein works in the liver could lead to a more effective type 2 diabetes drug.
Sep 2, 2020
0
140
Launching a two-pronged attack on cancer's ability to safeguard its DNA could offer an effective new way of treating the disease, a new study reports.
Mar 12, 2020
0
335
Heart disease remains the largest killer in Australia and around the world. A new study has shown that a protein therapy- recombinant human platelet-derived growth factor-AB (rhPDGF-AB) - could improve outcomes following ...
Jan 2, 2020
0
332
A therapy that targets the immune system showed promise for treating atopic dermatitis—the most common form of eczema—in a small proof-of-concept trial, led by scientists from the Medical Research Council Human Immunology ...
Oct 23, 2019
0
101